logo
Eleos Deepens Post-Acute Care Mission with Home Health, Palliative, and Hospice Care Expansion

Eleos Deepens Post-Acute Care Mission with Home Health, Palliative, and Hospice Care Expansion

Toronto Star28-07-2025
CHICAGO and BOSTON, July 28, 2025 (GLOBE NEWSWIRE) — Eleos Health, the market leader in AI for behavioral health, announced its expansion deeper into post-acute care, bringing its trusted, purpose-built AI platform to home health, palliative care and hospice settings. At the 2025 National Alliance for Care at Home Financial Summit on July 28 in Chicago, Eleos will showcase how AI can ease documentation burdens, ensure compliance and improve care quality across the post-acute landscape.
By 2034, Americans over the age of 65+ will outnumber children 18 and under. The U.S. home hospice market alone is estimated to reach over $75 billion by 2032. The already heavy documentation burden for in-home care providers will explode as these demographic trends continue unless providers can access innovative tools and solutions.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Arteris To Provide FlexGen Smart NoC IP In Next-Generation AMD AI Chiplet Designs
Arteris To Provide FlexGen Smart NoC IP In Next-Generation AMD AI Chiplet Designs

Globe and Mail

time33 minutes ago

  • Globe and Mail

Arteris To Provide FlexGen Smart NoC IP In Next-Generation AMD AI Chiplet Designs

CAMPBELL, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- In a market reshaped by the compute demands of AI, Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor system IP for accelerating system-on-chip (SoC) creation, today announced AMD (Nasdaq: AMD), a global leader in high-performance and adaptive computing, has licensed FlexGen network-on-chip (NoC) interconnect IP for its next generation of AI chiplet design. FlexGen, Arteris' smart NoC IP technology, will provide high-performance data transport in AMD chiplets powering AI across the company's broad portfolio which spans from data centers to edge and end devices. The strategic combination and interoperability of Arteris' FlexGen NoC IP with the AMD Infinity Fabric™ interconnect underscores the increasing complexity of modern SoCs and chiplet-based architectures, which now require multiple highly specialized interconnects or NoCs to efficiently meet the demands of modern electronic systems. 'We are excited to collaborate and expand our relationship with AMD, a company recognized globally for its innovation in high performance computing,' said K. Charles Janac, president and CEO of Arteris. 'With modern chiplets each having between 5 and 20 interconnect networks for data transport, our FlexGen NoC IP will work hand in hand with AMD's Infinity Fabric to accelerate the performance and scalability required by today's most demanding and diverse applications. This latest engagement with AMD exemplifies the transformative impact of Arteris' NoC technology in delivering next-generation silicon solutions for a wide range of markets from the data center to the edge.' 'AMD is driving innovations that scale AI from cloud to client by continually developing leadership computing technologies and best-in-class IP,' said Mydung Pham, corporate vice president silicon design engineering at AMD. 'Integrating Arteris' FlexGen NoC IP technology into a range of AMD chiplets, we can automate interconnect configuration and enable seamless connectivity among SoC components while strengthening the best end-to-end AI compute portfolio in the industry.' Arteris is an industry leader in flexible and configurable network-on-chip IP technology. FlexGen, Arteris' latest NoC IP innovation, is specifically designed to make designing SoCs more efficient and to optimize wire length, reduce latency, and improve power efficiency, addressing the communication and performance needs of increasingly complex multi-die and chiplet-based designs. FlexGen can be utilized as an independent interconnect solution or in combination with proprietary interconnect technology to accelerate design iterations and time to market schedules. Arteris continues to revolutionize SoC and chiplet performance with innovative technology. FlexGen smart NoC IP leverages AI automation to enhance design productivity through streamlined iteration cycles, and position companies to address the complexities of today's computing systems while dreaming up what comes next. Learn more at About Arteris Arteris is a global leader in system IP used in semiconductors to accelerate the creation of high-performance, power-efficient silicon. Arteris network-on-chip (NoC) interconnect IP and system-on-chip (SoC) integration automation software are used by the world's top semiconductor and technology companies to improve overall performance, engineering productivity, reduce risk, lower costs, and bring complex designs to market faster. Learn more at © 2004-2025 Arteris, Inc. All rights reserved worldwide. Arteris, Arteris IP, the Arteris IP logo, and the other Arteris marks found at are trademarks or registered trademarks of Arteris, Inc. or its subsidiaries. All other trademarks are the property of their respective owners.

Buy AMD Stock for New Peaks as Q2 Earnings Approach?
Buy AMD Stock for New Peaks as Q2 Earnings Approach?

Globe and Mail

time38 minutes ago

  • Globe and Mail

Buy AMD Stock for New Peaks as Q2 Earnings Approach?

AMD AMD will be a highlight of this week's earnings lineup, with the chip leader set to release its Q2 report after-market hours on Tuesday, August 5. Like Nvidia NVDA, which is scheduled to report later in the month, AMD stock has been performing well due to a combination of strategic product launches, strong AI demand, and favorable market conditions. Recently hitting a 52-week high of $182 a share, let's see if fresh peaks are in store for AMD stock as its Q2 earnings approach. AI Momentum & Data Center Growth Gaining traction from major companies like Oracle ORCL, Tesla TSLA, and OpenAI, AMD's MI355X Graphic Processing Unit (GPU) is reported to deliver over 7X the compute power of its previous high-powered AI chip, the MI325X, and has become a serious contender to Nvidia's offerings. Thanks to strong demand for AI accelerators, AMD has raised the price of its MI350 series chips to over $20,000. This is a great sign ahead of AMD's Q2 report, as the company's Central Processing Units (CPUs) and GPUs led to a 57% surge in its data center revenue in Q1. Also fueling investor sentiment is that recent U.S. policy shifts have loosened export restrictions, allowing AMD to resume its chip shipments to China and potentially adding hundreds of millions in revenue. Rebounding and surging over +70% in the last three months, AMD stock is now up +45% year to date to impressively top the S&P 500 and Nasdaq's returns of +6% and +8% respectively, while even topping Nvidia's +32%. AMD's Q2 Expectations With analysts expecting another strong quarter of data center growth, AMD's Q2 sales are expected to be up 27% to $7.41 billion compared to $5.84 billion a year ago. However, AMD is also facing the impact of competitive pricing in the CPU and GPU market, with Q2 earnings thought to have dipped to $0.47 a share compared to EPS of $0.69 in the prior period. Attributing to margin pressures, higher R&D spending on its next-generation GPUs is thought to have weighed on AMD's bottom line during Q2 as well. That said, AMD has reached or exceeded the Zacks EPS Consensus for 25 consecutive quarters, dating back to April of 2019, and has posted an average EPS surprise of 2.3% over its last four quarterly reports. Plus, AMD is still projected to post double-digit top and bottom line growth in fiscal 2025 and FY26, but Wall Street is very much anticipating the company's Q3 guidance to see if the chipmaker can sustain its growth trajectory. Monitoring AMD's Valuation Like most of the leading chipmakers, AMD stock trades at a premium to the broader market at 44X forward earnings. While this is above the benchmark S&P 500's 23.3X, AMD is roughly on par with Broadcom's AVGO forward P/E valuation and is near Nvidia's 40.7X. It's also noteworthy that AMD trades far more reasonably than some of its AI chip-producing peers in terms of price-to-sales. In this regard, AMD has a forward P/S ratio of 8.7X, with Nvidia and Broadcom stock trading over 20X forward sales. Bottom Line For now, AMD stock lands a Zacks Rank #3 (Hold). To that point, it wouldn't be surprising if AMD stock hit new peaks, although better buying opportunities could be ahead after such a monstrous rally over the last three months. Keeping this in mind, AMD's Q2 report and guidance will be critical to more upside. Zacks Names #1 Semiconductor Stock This under-the-radar company specializes in semiconductor products that titans like NVIDIA don't build. It's uniquely positioned to take advantage of the next growth stage of this market. And it's just beginning to enter the spotlight, which is exactly where you want to be. With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $971 billion by 2028. See This Stock Now for Free >> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Advanced Micro Devices, Inc. (AMD): Free Stock Analysis Report NVIDIA Corporation (NVDA): Free Stock Analysis Report Oracle Corporation (ORCL): Free Stock Analysis Report Broadcom Inc. (AVGO): Free Stock Analysis Report Tesla, Inc. (TSLA): Free Stock Analysis Report

James River Announces Second Quarter 2025 Results
James River Announces Second Quarter 2025 Results

Toronto Star

time38 minutes ago

  • Toronto Star

James River Announces Second Quarter 2025 Results

PEMBROKE, Bermuda, Aug. 04, 2025 (GLOBE NEWSWIRE) — James River Group Holdings, Ltd. ('James River' or the 'Company') (NASDAQ: JRVR) reported net income from continuing operations available to common shareholders of $3.2 million ($0.07 per diluted share) and adjusted net operating income1 of $11.7 million ($0.23 per diluted share) for the second quarter of 2025. Unless specified otherwise, all underwriting performance ratios presented herein are for our continuing operations and business not subject to retroactive reinsurance accounting.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store